SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Devon Energy Corp. engages in the exploration, development, and production of oil and natural gas properties. It develops and operates Delaware Basin, Eagle Ford, Heavy Oil, Barnett Shale, STACK, and Rockies Oil. The company was founded by J. Larry Nichols and John W. Nichols in 1971 and is headquartered in Oklahoma City, OK.

Devon Energy Corp.

Devons sale of its Eagle Ford assets to Crescent is drawing attention, with traders debating whether the divestiture and cash proceeds will help streamline the company and unlock value or whether the stocks weak performance reflects broader concerns about management and its post-Coterra portfolio. The transaction is also being discussed amid activist pressure for further asset sales or a broader strategic review.

Coca-Cola Company (The). The Group's principal activities are manufacturing, distributing and marketing nonalcoholic beverage concentrates and syrups. The products of the Group include carbonated soft drinks and also various kinds of non carbonated beverages. The Group sells these beverages, concentrates and syrups to bottling and canning operations, distributors, fountain wholesalers and retailers. The other products marketed and distributed by the Group include juice drinks, sports drinks, water products, teas, coffees and other beverage products. The Group also has ownership interests in various canning and bottling operations. The operations of the Group are conducted in the United States, Europe, Eurasia, Middle East, Africa, Latin America and Asia.

Coca-Cola Co

Coca-Colas better-than-expected second-quarter results and raised full-year outlook are driving attention, with traders pointing to resilient beverage demand and stronger volume growth. Many welcome the post-earnings rally and view KO as a defensive holding, while others warn that the stock looks overvalued or stretched and may pull back.

Datadog, Inc. engages in the development of a monitoring and analytics platform for developers, information technology operations teams and business users. Its platform integrates and automates infrastructure monitoring, application performance monitoring and log management to provide real-time observability of its customers' entire technology stack. The company was founded by Olivier Pomel and Alexis Lê-Quôc on June 4, 2010 and is headquartered in New York, NY.

Datadog Inc - Ordinary Shares - Class A

Datadog Inc

Datadog is drawing attention after a sharp rally to a new 52-week high, with traders pointing to an analyst upgrade and continued cloud and AI workload demand alongside a broader software-sector bid. Momentum-focused bulls see a breakout, while skeptics cite the stocks rich valuation and warn the advance may be overextended.

Fastly, Inc. provides real-time content delivery network services. It offers edge compute, edge delivery, edge security, edge applications like load balancing and image optimization, video on demand, and managed edge delivery. The company was founded by Artur Bergman, Tyler McMullen, Simon Wistow, and Gil Penchina in March 2011 and is headquartered in San Francisco, CA.

Fastly Inc - Ordinary Shares - Class A

Fastly Inc

Oppenheimers upgrade to Outperform has sparked a sharp rally, with the analyst citing larger deals and potential growth from security products and agentic AI traffic. Traders are bullish on a possible rerating and short squeeze, while others warn that Fastlys volatile rallies have faded before and say the AI revenue thesis still needs validation.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax rallied with other vaccine stocks after a report of an NIH/NCI push for personalized cancer vaccines. Traders debate whether NVAXs move is mainly sympathy buying, since it has no cancer-vaccine program, or whether its Matrix-M adjuvant could benefit; many also point to Sanofis authorized COVID-flu Phase 3 trial and a potential milestone payment, which has not yet been confirmed as triggered.

Select Sector SPDR Trust (The) - State Street Energy Select Sector SPDR ETF

Energy Select Sector SPDR Fund

Geopolitical risk around the Iran conflict, Strait of Hormuz shipping and attacks on Saudi energy infrastructure is driving discussion of elevated oil prices and supply disruption, including tight refined-fuel markets. Traders are divided between seeing these risks as support for energy stocks and expecting a pullback if diplomacy or restored flows ease the risk premium.

e.l.f. Beauty, Inc. is a holding company, which engages in the provision of inclusive, accessible, clean, vegan and cruelty free cosmetics and skin care products. The company focuses on the e-commerce, national retailers and international business channels. Its brands include elf, elf skin, naturium, well people, and keys soulcare. The company was founded in 2004 and is headquartered in Oakland, CA.

e.l.f. Beauty Inc

e.l.f. Beautys strong quarterly results and raised full-year outlook, alongside momentum from Rhode and international expansion, are driving bullish attention. Traders remain divided over whether the growth justifies the valuation, with higher marketing costs and profit-taking cited as reasons for caution after the stocks rebound.

Aerodrome Finance is a next-generation AMM designed to serve as Base's central liquidity hub, combining a powerful liquidity incentive engine, vote-lock governance model, and friendly user experience. Aerodrome inherits the latest features from Velodrome V2.

Aerodrome Finance

AERO is drawing attention amid a rally and anticipation around the AerodromeVelodrome merger and a planned expansion into Ethereum and other chains, which traders see as broadening its reach beyond Base. Many are bullish on the rollout and price momentum, while others warn of a pullback or a sell-the-news reaction and point to token emissions as a risk.

X-Energy, Inc. engages in the development of advanced small modular nuclear reactors and fuel technology for clean energy generation. Its solutions include Xe-100 and TRISO-X. The company was founded by Kam Ghaffarian and Eben Mulder in 2009 and is headquartered in Rockville, MD.

X-Energy Inc. - Ordinary Shares- Class A

X-Energy Inc

XE is drawing attention amid a sharp post-IPO selloff, which traders link to a bearish analyst rating, the lockup expiry and weakness across speculative nuclear stocks. Some see further downside and question its valuation before reactor commercialization, while others are buying dips based on Amazons backing, federal support and expected demand for nuclear power from data centers.

Affirm Holdings, Inc. operates a platform for digital and mobile-first commerce. Its platform consists of three core elements: a point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. The company was founded by Max R. Levchin in 2012 and is headquartered in San Francisco, CA.

Affirm Holdings Inc - Ordinary Shares - Class A

Affirm Holdings Inc

Affirms strong quarterly results and outlook, followed by a wave of analyst upgrades, have fueled bullish interest, but traders are also focused on the sharp post-earnings reversal and volatility. The debate centers on whether the pullback reflects profit-taking or concerns about higher rates, consumer credit risk, and the BNPL sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

NUVB is drawing attention amid sharp, high-volume swings and reports of rising short interest, with traders debating whether the selling reflects institutional activity or could set up short covering; those claims remain speculative. The discussion is also focused on upcoming Q3 results as a test of IBTROZIs commercial uptake, while investors weigh its launch prospects and competition.

Why Is Nuvation Bio Stock Gaining Thursday?

Nuvation Bio (NUVB) stock jumps 6% after early FDA label update for IBTROZI, highlighting over 4 years of clinical benefit in ROS1+ NSCLC.read more...

Nuvation Bio Announces FDA Approval of Supplemental New Drug Application for IBTROZI (taletrectinib) with Updated Duration of Response in TKI-Nave Advanced ROS1-Positive Non-Small Cell Lung Cancer

Nuvation Bio Announces FDA Approval of Supplemental New Drug Application for IBTROZI (taletrectinib) with Updated Duration of Response in TKI-Nave Advanced ROS1-Positive Non-Small Cell Lung Cancer Nuvation Bio Announces FDA Approval of Supplemental New Drug Application for IBTROZI (taletrectinib...

Nuvation Bio Announces New Analyses Reinforcing the Durable, Consistent Efficacy of IBTROZI (taletrectinib) Across Key Patient Subgroups in Advanced ROS1+ NSCLC at 2026 World Conference on Lung Cancer

Nuvation Bio Announces New Analyses Reinforcing the Durable, Consistent Efficacy of IBTROZI (taletrectinib) Across Key Patient Subgroups in Advanced ROS1+ NSCLC at 2026 World Conference on Lung Cancer Nuvation Bio Announces New Analyses Reinforcing the Durable, Consistent Efficacy of IBTROZI...

Jim Cramer: This Health Care Stock Is Pure Spec, The Only Neocloud I Like Is...

Cramer calls Nuvation Bio a pure spec, prefers CoreWeave over IREN, is unsure on Seneca, cautious on NuScale, and approves Box.read more...

Cramer's lightning round: Nuvation Bio 'is a pure spec'

"Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed...

Does Nuvation Bio (NUVB) Have the Potential to Rally 91.92% as Wall Street Analysts Expect?

The average of price targets set by Wall Street analysts indicates a potential upside of 91.9% in Nuvation Bio (NUVB). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Nuvation Bio to Participate in Upcoming Investor Conferences

Nuvation Bio to Participate in Upcoming Investor Conferences Nuvation Bio to Participate in Upcoming Investor Conferences PR Newswire NEW YORK, Sept. 2, 2026 NEW YORK, Sept. 2, 2026 /PRNewswire/ -- Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on tackling some of the toughest...

Nuvation Bio (NUVB) Upgraded to Buy: Here's Why

Nuvation Bio (NUVB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Nuvation Bio Granted FDA Fast Track Designation for Safusidenib for Treatment of IDH1-Mutant Glioma

Nuvation Bio Granted FDA Fast Track Designation for Safusidenib for Treatment of IDH1-Mutant Glioma Nuvation Bio Granted FDA Fast Track Designation for Safusidenib for Treatment of IDH1-Mutant Glioma PR Newswire NEW YORK, Aug. 20, 2026 Designation offers pathway to expedite regulatory review...

Wall Street Analysts Predict a 105.71% Upside in Nuvation Bio (NUVB): Here's  What You Should Know

The mean of analysts' price targets for Nuvation Bio (NUVB) points to a 105.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Nuvation Bio, Inc. is a biopharmaceutical company tackling some of the unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. The company was founded by David Hung on March 20, 2018 and is headquartered in New York, NY.

Nuvation Bio Inc - Ordinary Shares - Class A

NUVB Stock Is Soaring Today — Why RBC Sees $3B Opportunity In Nuvation Bio's Brain Cancer Drug

Equity

Bearish Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Stocktwits

Stocktwits Polls

The community is fixated on the upcoming quarterly report to validate commercial revenue growth for Ibtrozi.

Current Price	$5.00
Prev Close	$4.95
Open	$4.95
Dividend Yield	0.00%
50-Day Moving Average	$6.18
Beta	1.63
Avg. Volume	4.76M
PE Ratio	-11.49

52-Week High	$9.75
52-Week Low	$3.36
Market Capitalization	$1.76B
EPS (Annual)	-$0.5991
Price to Book	6.89
Revenue Per Employee	$211,080.54

Feed

News

Sentiment

Earnings

Fundamentals

Info

NUVB Fundamentals